1. Home
  2. VNET vs HCM Comparison

VNET vs HCM Comparison

Compare VNET & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VNET Group Inc.

VNET

VNET Group Inc.

HOLD

Current Price

$7.72

Market Cap

2.5B

Sector

Technology

ML Signal

HOLD

Logo HUTCHMED (China) Limited

HCM

HUTCHMED (China) Limited

HOLD

Current Price

$11.20

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VNET
HCM
Founded
1999
2000
Country
China
Hong Kong
Employees
N/A
1796
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.3B
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
VNET
HCM
Price
$7.72
$11.20
Analyst Decision
Strong Buy
Sell
Analyst Count
1
1
Target Price
$12.60
$13.75
AVG Volume (30 Days)
4.6M
46.9K
Earning Date
05-27-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$20.06
$20.60
Revenue Next Year
$21.04
$15.62
P/E Ratio
N/A
$5.49
Revenue Growth
N/A
N/A
52 Week Low
$7.10
$9.77
52 Week High
$14.48
$19.50

Technical Indicators

Market Signals
Indicator
VNET
HCM
Relative Strength Index (RSI) 43.69 51.39
Support Level $7.68 $9.77
Resistance Level $9.41 $11.81
Average True Range (ATR) 0.43 0.27
MACD 0.02 0.07
Stochastic Oscillator 31.02 46.23

Price Performance

Historical Comparison
VNET
HCM

About VNET VNET Group Inc.

VNET started as AsiaCloud in 1999 and moved into the data center business, opening its first self-developed data center in 2010. The firm listed (as 21Vianet) on the Nasdaq in April 2011, subsequently changing its name to VNET Group in 2021. It originally focused on providing data center services such as colocation and cloud services to retail clients in China, but added hyperscale customers in 2019 and now counts large Chinese hyperscalers such as Alibaba Cloud, Tencent Cloud, and Huawei Cloud as customers. At the end of September 2025, it had 52,288 retail cabinets, with the majority in Beijing, Shanghai, and the Greater Bay area. It also had 783 MW of wholesale capacity in service, with a further 306 MW under construction and a further 705 MW held for future development.

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.

Share on Social Networks: